University of Pennsylvania Health System

Department of Ophthalmology

Ophthalmology Faculty

Brian VanderBeek, MD, MPH

faculty photo
Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania
Department: Ophthalmology

Contact information
Scheie Eye Institute
51 N. 39th Street
Philadelphia, PA 19104
B.A. (Biology)
University of Michigan, School of Literature, Science & Arts, 1999.
M.P.H (Toxicology)
University of Michigan, School of Public Health, 2001.
University of Cincinnati College of Medicine, 2005.
University of Pennsylvania School of Medicine, 2015.
Post-Graduate Training
Intern - Internal Medicine, Christ Hospital - Cincinnati, Ohio, 2005-2006.
Ophthalmology Resident, New York Presbyterian Hospital Weill Cornell Medical College - New York, NY, 2006-2009.
Lecturer and Fellow, Retina, Uveitis, and Ocular Oncology , University of Michigan Kellogg Eye Center - Ann Arbor, MI, 2009-2011.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

VanderBeek BL, Bonaffini SG, Ma L : The impact of intravitreal drugs on rates of post-injection endophthalmitis. International Conference on Pharmacoepidemiology, Boston, MA Aug 2015 Notes: Poster presentation.

VanderBeek Brian L, Bonaffini Sarah G, Ma Liyuan: Association of Compounded Bevacizumab With Postinjection Endophthalmitis. JAMA ophthalmology Aug 2015 Notes: Epub ahead of print.

VanderBeek Brian L, Bonaffini Sarah G, Ma Liyuan: The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates. Ophthalmology Aug 2015 Notes: Epub ahead of print.

VanderBeek Brian L: Re: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade. Retina (Philadelphia, Pa.) 35(7): e40-2, Jul 2015.

Bonaffini SG, VanderBeek BL: The changing rate of post intravitreal injection endophthalmitis: a 10-year study of a large U.S. national insurance database. Association for Research in Vision and Ophthalmology Annual Meeting, Denver, CO May 2015 Notes: Poster presentation.

Bressler Susan B, Almukhtar Talat, Bhorade Anjali, Bressler Neil M, Glassman Adam R, Huang Suber S, Jampol Lee M, Kim Judy E, Melia Michele: Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. JAMA ophthalmology 133(5): 589-97, May 2015.

Wells John A, Glassman Adam R, Ayala Allison R, Jampol Lee M, Aiello Lloyd Paul, Antoszyk Andrew N, Arnold-Bush Bambi, Baker Carl W, Bressler Neil M, Browning David J, Elman Michael J, Ferris Frederick L, Friedman Scott M, Melia Michele, Pieramici Dante J, Sun Jennifer K, Beck Roy W: Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. The New England journal of medicine 372(13): 1193-203, Mar 2015.

VanderBeek BL, Lee V: Geographic Atrophy: A Histopathologic Assessment. Year Book of Ophthalmology 2015. Elseveir Publishing, Philadelphia, PA 2015.

Ghodasra Devon H, Eftekhari Kian, Shah Ankoor R, VanderBeek Brian L: Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting. Ophthalmology 121(12): 2334-9, Dec 2014.

Eftekhari Kian, Ghodasra Devon H, Haynes Kevin, Chen Jinbo, Kempen John H, VanderBeek Brian L: Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiology and drug safety 23(7): 745-52, Jul 2014.

back to top
Last updated: 09/02/2015
The Trustees of the University of Pennsylvania